Neurogenic Bladder: from Diagnosis to Management
- 1.3k Downloads
Patients with spinal cord injury (SCI) present with a wide range and variety of urologic manifestations, depending upon the level of injury. Historically, patients with spinal cord injury experienced significant mortality related to renal failure. Greater knowledge of the pathophysiology of SCI, however, has contributed to a reduction in mortality. It is essential to perform a thorough initial evaluation and regular follow-up of these patients to achieve the primary goal of preservation of renal function, with the secondary goal of optimizing the patient’s quality of life.
KeywordsSpinal cord injury Neurogenic bladder Bladder dysfunction Urodynamics Voiding dysfunction
Compliance with Ethics Guidelines
Conflict of Interest
Dr. Ellen Goldmark and Dr. Benjamin Niver each report no potential conflicts of interest.
Dr. David A. Ginsberg is a consultant and investigator for Allergan.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Bodner DR, Witcher M, Resnick MI. Application of office ultrasound in the management of the spinal cord injury patient. J Urol. 1990;143(5):969–72.Google Scholar
- 2.Shingleton WB, Bodner DR. The development of urologic complications in relationship to bladder pressure in spinal cord injured patients. J Am Paraplegia Soc. 1993;16(1):14–7.Google Scholar
- 3.Morcos SK, Thomas DG. A comparison of real-time ultrasonography with intravenous urography in the follow-up of patients with spinal cord injury. Clin Radiol. 1988;39(1):49–50.Google Scholar
- 4.Hamid R, Bycroft J, Arya M et al. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol. 2003;170:425–427.Google Scholar
- 5.Gousse AE, Meinbach DS, Kester RR et al. Renal ultrasound correlates with renal nuclear scan in upper tract surveillance of spinal cord-injured patients. Top Spinal Cord Inj Rehabil. 2003;8(3):1–7.Google Scholar
- 6.Killorin W, Gray M, Bennett JK et al. The value of urodynamics and bladder management in predicting upper urinary tract complications in male spinal cord injury patients. Paraplegia. 1992;30(6):437–441.Google Scholar
- 8.National Spinal Cord Injury Statistical Center, Facts and Figures at a Glance. 2/2013 [cited 2014 February 25]; Available from: www.nscisc.uab.edu/publicdocuments/fact_figures_docs/facts%202013.pdf).
- 10.Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med. 2006;29(5):527–73.Google Scholar
- 14.•Sorokin I, De E. Options for independent bladder management in patients with spinal cord injury and hand function prohibiting intermittent catheterization. Neurourol Urodyn. 2013. Important, as one cannot underestimate the difficulty with independent bladder management in this patient population due to limited upper extremity dexterity. Google Scholar
- 46.•Stohrer M et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56(1):81–8. Important as this provides European guidelines on management of neurogenic bladder patients. Although not a U.S. based guideline, still can be used to see how these patients are best managed.PubMedCrossRefGoogle Scholar
- 52.••Cruz F et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60(4):742–50. Very important – this, along with study by Ginsberg et al., demonstrated that BoNT-A could be used in this patient population, which is a very important aspect of treating NDO today.PubMedCrossRefGoogle Scholar
- 53.••Ginsberg D et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012;187(6):2131–9. Very important – this, along with study by Cruz et al., demonstrated that BoNT-A could be used in this patient population.PubMedCrossRefGoogle Scholar
- 54.Abrams P et al. Sixth report on the standardisation of terminology of lower urinary tract function. Procedures related to neurophysiological investigations: electromyography, nerve conduction studies, reflex latencies, evoked potentials and sensory testing. The International Continence Society Committee on Standardisation of Terminology, New York, May 1985. Scand J Urol Nephrol. 1986;20(3):161–4.PubMedCrossRefGoogle Scholar
- 55.Goldmark E, Yuh B, Ginsberg D. Changes in bladder management in patients with neurogenic bladder with FDA approval of Onabotulinumtoxin A: aRetrospective review. 2014: In: SUFU Meeting. 2014.Google Scholar